Loading…
Company must meet specific conditions to maintain Nasdaq listing.
Glucotrack, Inc. (GCTK) received notification from the Nasdaq Hearings Panel that its request for continued listing has been granted, contingent upon meeting certain conditions. The decision was communicated following a review process.
The conditions set by the Nasdaq Hearings Panel are designed to ensure Glucotrack complies with listing requirements going forward. The company now has a specified period to meet these conditions to maintain its Nasdaq listing status.
As of the latest available data, Glucotrack has a free float of 6,200,880 shares.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.